Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Sana narrows focus again to zero in on diabetes and autoimmune disease
7 months ago
R&D
Viking CEO on ‘shocking’ market reaction to oral obesity data, preparing for Phase 3
7 months ago
R&D
Manufacturing
FDA cites Mark Cuban's drug compounding center in Dallas with sterility, quality concerns
7 months ago
Pharma
FDA+
The election is Tuesday. What’s at stake for the pharma industry?
7 months ago
Pharma
FDA+
Rare disease biopharma companies weigh in on FDA's new innovation hub
7 months ago
FDA+
BioNTech eases 2024 revenue outlook despite hefty Covid vaccine third-quarter sales
7 months ago
Pharma
FDA expands faster drug review pilot from supplemental to full applications
7 months ago
Pharma
FDA+
BioNTech says VEGF bispecific’s PD-L1 target, combo plans will be its edge
7 months ago
R&D
Pharma
Novo, Ascendis to work on monthly GLP-1; KalVista makes a royalty deal
7 months ago
News Briefing
'We play to win': AstraZeneca details first results for oral GLP-1 and broader obesity ambitions
7 months ago
R&D
Pharma
Is there room for MASH drugs in a GLP-1 world?
7 months ago
R&D
Pharma
European Commission marks Dec. 6 for Novo-Catalent deal decision
7 months ago
Deals
Manufacturing
Viking's oral weight loss drug appears to have strong effect in Phase 1 trial
7 months ago
R&D
Pharma
Novo adds to Wegovy’s cardio strength with hospital admissions analysis
7 months ago
Pharma
CinRx touts positive early-stage data from two obesity candidates
7 months ago
R&D
How RFK Jr. might influence the FDA; Pharma's Q3 highlights; AbbVie's latest neuro buyout; and more
7 months ago
Weekly
BMS, J&J and AstraZeneca plea with appeals court to overturn drug price negotiations
7 months ago
Pharma
Law
Exclusive: Women’s health unicorn Maven Clinic cuts 10% of its workforce weeks after raising $125M
7 months ago
People
Health Tech
Heritage and Apotex to pay $49.1M in price-fixing settlement
7 months ago
Pharma
Law
Novo Nordisk claims late-stage MASH victory, continuing GLP-1's expansion
7 months ago
R&D
FDA removes hold on three CARsgen CAR-T trials; Ono passes on itolizumab
7 months ago
News Briefing
Exclusive: Blood stem cell therapy maker Garuda gets new CEO, adds $47M
7 months ago
Financing
Cell/Gene Tx
Baxter pulls IV products out of China to shift supply to the US
7 months ago
China
Manufacturing
Essa’s shares tank as it looks for options after abandoning prostate cancer drug
7 months ago
R&D
First page
Previous page
81
82
83
84
85
86
87
Next page
Last page